Patents by Inventor Heidi Maria Florence Jonckheere

Heidi Maria Florence Jonckheere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serum albumin binding proteins with long half-lives
    Publication number: 20100113339
    Abstract: The present invention relates to amino acid sequences that are capable of binding to serum albumin; to compounds, proteins and polypeptides comprising or essentially consisting of such amino acid sequences; to nucleic acids that encode such amino acid sequences, proteins or polypeptides; to compositions, and in particular pharmaceutical compositions, that comprise such amino acid sequences, proteins and polypeptides; and to uses of such amino acid sequences, proteins and polypeptides.
    Type: Application
    Filed: September 10, 2007
    Publication date: May 6, 2010
    Applicant: Ablynx N. V.
    Inventors: Els Anna Alice Beirnaert, Hilde Adi Pierrette Meise, Hendricus Renerus Jacobus Mattheus Hoogenboon, Heidi Maria Florence Jonckheere, Torsten Dreier
  • Serum albumin binding proteins with long half-lives
    Publication number: 20070269422
    Abstract: The present invention relates to amino acid sequences that are capable of binding to serum albumin; to compounds, proteins and polypeptides comprising or essentially consisting of such amino acid sequences; to nucleic acids that encode such amino acid sequences, proteins or polypeptides; to compositions, and in particular pharmaceutical compositions, that comprise such amino acid sequences, proteins and polypeptides; and to uses of such amino acid sequences, proteins and polypeptides. Particularly, the amino acid sequences and compounds of the present invention bind to or otherwise associate with serum albumin in such a way that, when the amino acid sequence or compound is bound to or otherwise associated with a serum albumin molecule in a primate, it exhibits a serum half-life of at least 50% of the natural half-life of serum albumin in said primate.
    Type: Application
    Filed: September 8, 2006
    Publication date: November 22, 2007
    Applicant: Ablynx N.V.
    Inventors: Els Beirnaert, Hilde Adi Pierrette Revets, Hendricus Renerus Jacobus Mattheus Hoogenboom, Heidi Maria Florence Jonckheere, Torsten Dreier